Cargando…
S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428489/ http://dx.doi.org/10.1097/01.HS9.0000967956.37234.fb |
| _version_ | 1785090482587566080 |
|---|---|
| author | Dickinson, Michael Hamad, Nada Bryant, Christian Kothari, Nishi Ojeras, Paulius Vohra, Anmol Lin, Ming Tohme, Mira Trager, James Shook, David Kennedy, Glen Tees, Michael Hill, Brian T. |
| author_facet | Dickinson, Michael Hamad, Nada Bryant, Christian Kothari, Nishi Ojeras, Paulius Vohra, Anmol Lin, Ming Tohme, Mira Trager, James Shook, David Kennedy, Glen Tees, Michael Hill, Brian T. |
| author_sort | Dickinson, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428489 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284892023-08-17 S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES Dickinson, Michael Hamad, Nada Bryant, Christian Kothari, Nishi Ojeras, Paulius Vohra, Anmol Lin, Ming Tohme, Mira Trager, James Shook, David Kennedy, Glen Tees, Michael Hill, Brian T. Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428489/ http://dx.doi.org/10.1097/01.HS9.0000967956.37234.fb Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Dickinson, Michael Hamad, Nada Bryant, Christian Kothari, Nishi Ojeras, Paulius Vohra, Anmol Lin, Ming Tohme, Mira Trager, James Shook, David Kennedy, Glen Tees, Michael Hill, Brian T. S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES |
| title | S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES |
| title_full | S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES |
| title_fullStr | S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES |
| title_full_unstemmed | S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES |
| title_short | S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES |
| title_sort | s261: first in human data of nkx019, an allogeneic car nk for the treatment of relapsed/refractory (r/r) b-cell malignancies |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428489/ http://dx.doi.org/10.1097/01.HS9.0000967956.37234.fb |
| work_keys_str_mv | AT dickinsonmichael s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies AT hamadnada s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies AT bryantchristian s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies AT kotharinishi s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies AT ojeraspaulius s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies AT vohraanmol s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies AT linming s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies AT tohmemira s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies AT tragerjames s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies AT shookdavid s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies AT kennedyglen s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies AT teesmichael s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies AT hillbriant s261firstinhumandataofnkx019anallogeneiccarnkforthetreatmentofrelapsedrefractoryrrbcellmalignancies |